Pulmonary function during lung cancer therapy: A retrospective analysis of patients treated with monotherapy or multimodal treatments

Amanda Tufman (Muenchen, Germany), Amanda Tufman, Ariane Gallace, Kathrin Kahnert, Katrin Milger, Rudolf Maria Huber

Source: International Congress 2016 – Clinical aspects of lung cancer
Session: Clinical aspects of lung cancer
Session type: Thematic Poster
Number: 2823
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Amanda Tufman (Muenchen, Germany), Amanda Tufman, Ariane Gallace, Kathrin Kahnert, Katrin Milger, Rudolf Maria Huber. Pulmonary function during lung cancer therapy: A retrospective analysis of patients treated with monotherapy or multimodal treatments. Eur Respir J 2016; 48: Suppl. 60, 2823

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diaphragm motion and lung function prediction in patients operated for lung cancer – A pilot study on 27 patients
Source: Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome
Year: 2013

Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment?
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015

Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016

Is there a change in pulmonary function in patients with COPD and primary lung cancer treated with radiofrequency ablation (RFA)?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014



Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016

Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015

A phase III randomised trial testing chemotherapy in extensive small-cell lung cancer (SCLC)
Source: International Congress 2016 – Therapeutic trials in lung cancer
Year: 2016

Stereotactic ablative radiotherapy (SABR) in non-surgical non small cell lung cancer: Effects on respiratory function
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


The rate of curative intended therapy against recurrent lung cancer before and after introduction of a CT-based follow-up program
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013


Efficacy of preoperative comprehensive pulmonary rehabilitation in patients with lung cancer
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016

Cardio-respiratory exercise testing in the pre-surgical evaluation of lung cancer patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013


Pemetrexed in maintenance therapy of 164 patients with advanced non-small-cell lung cancer (NSCLC)
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015


Gene therapy with DDMC-p53 with or without cisplatin and microwave ablation. A future concept for local treatment in lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015

Poor prognostic factors in advanced pulmonary adenocarcinoma patients receiving first-line gefitinib
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013

Physiological predictors of mortality in high-risk patients undergoing surgery for lung cancer
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016


The impact of pulmonary rehabilitation on preoperative inflammatory markers in lung cancer patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013

Risk factors for prolonged postoperative air leak-a retrospective analysis of 853 partial lung resections for non-small cell lung cancer
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013


The role of second line chemotherapy in small cell lung cancer: A retrospective analysis
Source: Annual Congress 2013 –Advances in the therapy of lung cancer
Year: 2013

Clinicopathological characteristics and treatment outcomes of pulmonary carcinosarcoma in eight patients
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015